Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Arthrocare considers future

This article was originally published in The Gray Sheet

Executive Summary

ArthroCare, maker of minimally invasive Coblation devices that use low-temperature radiofrequency energy to gently dissolve soft tissue, said March 3 that its Board of Directors is evaluating financial and strategic alternatives, including recapitalization, stock repurchase, sale of assets or strategic business combinations. The board's decision is based on its belief that ArthroCare's current stock price - which closed March 3 at $43 - does not reflect the fundamental value of the business
Advertisement

Related Content

ArthroCare Restatement Will Cut Up To $37 Million From ’06-’08 Sales Reports
Advertisement
UsernamePublicRestriction

Register

MT025850

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel